The lipid membrane hypothesis of schizophrenia: Implications for possible clinical breath tests

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 1-2, 1996, Pages 95-99

  Dodd, G H ^a  

^a Craig Dunain Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; PENTANE;

BREATH ANALYSIS; CONFERENCE PAPER; HUMAN; LIPID MEMBRANE; MASS SPECTROMETRY; METHODOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0029768020     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90152-0     Document Type: Conference Paper

References (24)

1. Horrobin D. F. Schizoophrenia as a membrane lipid disorder which is expressed throughout the body. This symposiom.
2. Horrobin D. F. Schizophrenia as a prostaglandin dificiency disease. Lancet 1977; 1: 936-937.
3. Horrobin D. F. Mental Illness. In Horrobin D. F. Prostaglandins: Physiology, Pharmacology & Clinical Significance, Montreal: Eden Press, 1978: 242-253.
4. Horrobin D. F., Glen A. I., Vaddadi K. The membrane hypothesis of schizophrenia. Schiz. Res 1994; 13: 195-207.
5. 2 associated with schizophrenia. Nature Med in press?
6. Cherry R. J., Dodd G. H., Chapman D. Small molecule-lipid membrane interactions and the puncturing theory of olfaction. Biochim Biophys Acta 1970; 211: 407-413.
7. Persaud K., Dodd G. H. Analysis of discrimination mechanisms in the mammalian olfactory system using a model nose. Nature 1982; 299: 352-355.
8. Gardner J., Bartlett P., Dodd G. H., Shurtner H. The design of an artificial olfactory system. In Schild D., ed Chemosensory Information Processing, Springer-Verlag, 1990: 131-175.
9. Dodd G. H., Bartlett P., Gardner J. Complex sensor systems: odour detection by the sense of smell and by electronic noses. Biochem Soc Trans 1991; 19: 36-39.
10. Dodd G. H., Skinner M. From moods to molecules: the psychopharmacology of perfumery and aromatherapy. In Van Toller S., Dodd G. eds, Fragrance: the Psychology and Biology of Perfume, London: Elsevier, 1990: 113-142.
11. Katsuki H., Okuda S. Arachidonic acid as a neurotoxic and neurotrophic substance. Prog Neurobiol 1995; 46: 607-636.
12. Yao J. K., van Kammen D. P. Red blood cell membrane dynamics in schizophrenia 1. Membrane fluidity. Shiz Res 1994; 11: 209-216.
13. Gurr M. I., James A. T. Lipid Biochemistry, London: Chapman and Hall, 1980.
14. Chan H. W. (ed) Autoxidation of Unsaturated Lipids. London: Academic Press, 1987.
15. Saxby M. J. (ed) Food taints and off-flavours, London: Blackie, 1993.
16. Jansson B. O., Larsson B. T. Analysis of organic compounds on human breath by gas chromatography-mass spectrometry . J Lab Clin Med 1969; 74: 961-96.
17. Lawrence G. D., Cohen G. Concentrating ethane from breath to monitor lipid peroxidation in vivo. Methods Enzymol 1984; 105: 305-11.
18. Kovaleva E. S., Orlov O. N., Bogdanova ED et. al. Study of the processes of lipid peroxidation in patients with endogenous psychoses using gas chromatography. Zh Nevropatol Psikiatr 1989; 89: 99-103.
19. Kovaleva E. S., Orlov O. N., Tsutsul'kovskaia M. I., et al. Lipid peroxidation processes in patients with schizophrenia. Zh Nevropatol Psikiatr 1989; 89: 108-110.
20. Phillips M., Sabas M., Greenberg J. Increased pentane and carbon disulfide in the breath of patients with schizophrenia J Clin Pathol 1993; 46: 861-864.
21. Phillips M., Erickson G. A., Sabas M. et al. Volatile organic compounds in the breath of patients with schizophrenia. J Clin Pathol 1995; 48: 466-469.
22. Kneepkens C. M. F., Lepage G., Roy C. C. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radical Biol Med 1994; 17: 127-160.
23. Smith K., Thompson G., Koster H. Sweat in schizophrenic patients: identification of the odorous substance. Science 1969; 166: 398-399.
24. Gordon S., Smith K., Rabinowitz J. et al. Studies of trans-3-methyl-2-hexenoic acid in normal and schizophrenic subjects. J Lipid Res 1973; 14: 495-503.